Skip to main content
OpenTrials

Clinical trial condition

Immunologic Deficiency Syndromes

Explore clinical trials studying Immunologic Deficiency Syndromes. Study availability and eligibility vary by location and protocol.

6,136 public trials 392 recruiting studies
Refine in advanced search Browse all conditions

Immunologic Deficiency Syndromes trial results

Completed

Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Infected, Antiretroviral Treatment-Naive Adults

NCT01497899

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • University of Alabama at Birmingham (UAB) Birmingham, Alabama, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • AHF Research Center Beverly Hills, California, United States
  • Kaiser Permanente Los Angeles, California, United States
View all 41 locations
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of E/C/F/TAF (Genvoya®) Versus E/C/F/TDF (Stribild®) in HIV-1 Positive, Antiretroviral Treatment-Naive Adults

NCT01780506

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Spectrum Medical Group Phoenix, Arizona, United States
  • Kaiser Permanente Los Angeles Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
View all 117 locations
View Trial Details
Completed

Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced Adults

NCT01967940

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Midway Immunology and Research center Ft. Pierce, Florida, United States
  • Triple O Research Institute, P.A. West Palm Beach, Florida, United States
  • Rowan Tree Medical, P.A. Wilton Manors, Florida, United States
  • Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
View all 15 locations
View Trial Details
Completed

Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive Adults

NCT01968551

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Pueblo Family Physicians, Ltd. Phoenix, Arizona, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Kaiser Permanente Hayward, California, United States
  • Long Beach Education and Research Consultants Long Beach, California, United States
View all 62 locations
View Trial Details
Completed

HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections

NCT01384734

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site San Francisco, California, United States
  • GSK Investigational Site Washington D.C., District of Columbia, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 54 locations
View Trial Details

Related conditions